Enveric Biosciences Financial Statements 2009-2025 | ENVB

Revenue

$42.998

$48.594

$36.146

$20.261

Cost Of Goods Sold

$34.015

$38.356

$29.217

$13.392

Gross Profit

$8.984

$10.238

$6.928

$6.87

Research And Development Expenses

$2.841

$7.252

$8.028

$4.789

$0.174

SG&A Expenses

$6.454

$8.852

$11.606

$20.499

$5.322

$2.297

$10.795

$18.51

$9.362

$5.842

Other Operating Income Or Expenses

$6.607

$0.593

$-1.585

$-1.656

Operating Expenses

$16.13

$21.134

$12.308

$7.664

Operating Income

$-9.632

$-16.448

$-27.415

$-64.623

$-5.617

$-2.297

$-7.147

$-10.897

$-5.38

$-0.794

Total Non-Operating Income/Expense

$0.066

$-0.814

$7.458

$8.192

$-1.247

$-0.114

$-3.403

$-0.57

$-1.145

$-0.149

Pre-Tax Income

$-9.566

$-17.263

$-19.957

$-56.432

$-6.865

$-2.411

$-10.549

$-11.467

$-6.525

$-0.943

Income Taxes

$0.009

$0.029

$-1.486

$-7.455

$6.349

$-2.392

$-3.748

$-0.129

Income After Taxes

$-9.575

$-17.292

$-18.471

$-48.977

$-6.865

$-2.411

$-16.898

$-9.075

$-2.777

$-0.814

Other Income

Income From Continuous Operations

$-9.575

$-17.292

$-18.471

$-48.977

$-6.865

$-2.411

$-16.898

$-9.075

$-2.777

$-0.814

Income From Discontinued Operations

Net Income

$-9.575

$-17.459

$-18.8

$-48.977

$-6.865

$-2.411

$-19.481

$-11.164

$-2.781

$-0.814

EBITDA

$-9.295

$-16.04

$-19.526

$-25.263

$-5.208

$-2.228

$4.796

$-7.679

$-4.019

$-0.628

EBIT

$-9.632

$-16.448

$-27.415

$-64.623

$-5.617

$-2.297

$-7.147

$-10.897

$-5.38

$-0.794

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-19.04

$-121.29

$-194.90

$-1554.57

$-892.05

$-344.83

$-61379.31

$-56221.89

$-15742.13

$-5247.38

EPS - Earnings Per Share

$-19.04

$-121.29

$-194.90

$-1554.57

$-892.05

$-344.83

$-61379.31

$-56221.89

$-15742.13

$-5247.38